21 C.F.R. Subpart A—General Provisions
Title 21 - Food and Drugs
(a) In vitro diagnostic products are those reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. Such products are intended for use in the collection, preparation, and examination of specimens taken from the human body. These products are devices as defined in section 201(h) of the Federal Food, Drug, and Cosmetic Act (the act), and may also be biological products subject to section 351 of the Public Health Service Act. (b) A product class is all those products intended for use for a particular determination or for a related group of determinations or products with common or related characteristics or those intended for common or related uses. A class may be further divided into subclasses when appropriate. (c) [Reserved] (d) Act means the Federal Food, Drug, and Cosmetic Act. [41 FR 6903, Feb. 13, 1976, as amended at 45 FR 7484, Feb. 1, 1980] Data and information submitted under §809.10(c) that are shown to fall within the exemption established in §20.61 of this chapter shall be treated as confidential by the Food and Drug Administration and any person to whom the data and information are referred. The Food and Drug Administration will determine whether information submitted will be treated as confidential in accordance with the provisions of part 20 of this chapter. [45 FR 7484, Feb. 1, 1980]
Title 21: Food and Drugs
PART 809—IN VITRO DIAGNOSTIC PRODUCTS FOR HUMAN USE
Subpart A—General Provisions
§ 809.3 Definitions.
§ 809.4 Confidentiality of submitted information.
